Psoriasis: Difference between revisions
| (6 intermediate revisions by 4 users not shown) | |||
| Line 1: | Line 1: | ||
==Acceptability at Recruitment== | ==Acceptability at Recruitment== | ||
ACCEPTABLE except when associated with psoriatic arthritis | |||
==Acceptability at | Psoriatic arthritis | ||
NOT ACCEPTABLE | |||
==Acceptability at VT / Work-Up== | |||
Severe cases NOT ACCEPTABLE | Severe cases NOT ACCEPTABLE | ||
| Line 20: | Line 23: | ||
Acceptable | Acceptable | ||
=== Guidance at VT === | === Guidance at VT === | ||
| Line 28: | Line 30: | ||
Mild and moderate cases, treated with topical therapy (tar, creams etc...) or a single course of UV therapy (PUVA) are acceptable for BM only and may be acceptable for PBSC on a case-by-case basis and following discussion with donor regarding possibility of exacerbation. | Mild and moderate cases, treated with topical therapy (tar, creams etc...) or a single course of UV therapy (PUVA) are acceptable for BM only and may be acceptable for PBSC on a case-by-case basis and following discussion with donor regarding possibility of exacerbation. | ||
Use of retinoic acid derivatives: | |||
Unacceptable if ever taken Etretinate (Tigason). | |||
Acceptable: Donors having taken, or currently taking, acitretin (Neotigason) or Isotretinoin (Roaccutane) may join the register. | |||
*At VT/Work up, must inform transplant centre if a donor is taking any of these medications, or has done so at any point in the last 12 months. | |||
==Pseudonyms or Related Conditions== | ==Pseudonyms or Related Conditions== | ||
| Line 34: | Line 42: | ||
==Version== | ==Version== | ||
Version | Version 2, Edition 1 | ||
====Date of Last Update==== | ====Date of Last Update==== | ||
13th October 2026 | |||
Latest revision as of 08:51, 14 October 2026
Acceptability at Recruitment
ACCEPTABLE except when associated with psoriatic arthritis
Psoriatic arthritis NOT ACCEPTABLE
Acceptability at VT / Work-Up
Severe cases NOT ACCEPTABLE
Mild or moderate cases acceptable for BMH. May be acceptable for PBSC and this should be reviewed on a case-by-case basis.
Individual at Risk
Recipient
Explanation of Condition
Autoimmune condition causing scaling and redness of the skin, in characteristic patches.
See also Psoriasis
Guidance
Guidance at registration
Acceptable
Guidance at VT
Unacceptable if severe or widespread, or has ever suffered from psoriatic arthritis (joint involvement). Unacceptable if has received more than one course (up to three months) of UV treatment. Unacceptable if less than 1 year since completing course of systemic immunosuppression.
Mild and moderate cases, treated with topical therapy (tar, creams etc...) or a single course of UV therapy (PUVA) are acceptable for BM only and may be acceptable for PBSC on a case-by-case basis and following discussion with donor regarding possibility of exacerbation.
Use of retinoic acid derivatives:
Unacceptable if ever taken Etretinate (Tigason).
Acceptable: Donors having taken, or currently taking, acitretin (Neotigason) or Isotretinoin (Roaccutane) may join the register.
- At VT/Work up, must inform transplant centre if a donor is taking any of these medications, or has done so at any point in the last 12 months.
Pseudonyms or Related Conditions
Version
Version 2, Edition 1
Date of Last Update
13th October 2026